Generic name: elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil
Used for: HIV
Cash price
$4,500+ for 30 tablets
Pharmacies pay about this for Stribild; you’d pay more.
Free from the maker, if you qualify Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP). Or call 1-800-226-2056.
See if you qualifyNo generic is sold yet.
Details for each option
Savings card from Gilead Sciences
Or call 1-866-664-5327.
“Eligible patients could pay as little as $0 per month.”
From the maker’s offer on gilead.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.
There isn’t one. An authorized generic is Stribild itself, from the same company, sold without the brand name, and usually for less. For now Stribild is the only choice; its maker’s savings card can lower what you pay.
No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.
STRIBILD is a four-drug combination of elvitegravir, an HIV integrase strand transfer inhibitor (HIV-1 INSTI), cobicistat, a CYP3A inhibitor, and emtricitabine and tenofovir disoproxil fumarate (TDF), both HIV nucleoside analog reverse transcriptase inhibitors (HIV NRTI) and is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older weighing at least 35 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of STRIBILD.
Source: the FDA label for Stribild (Gilead Sciences, Inc.), February 4, 2025. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/stribild/